TMEM70 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.031000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.459200E-01
Normal-vs-Stage2
7.407400E-01
Normal-vs-Stage3
5.678600E-01
Normal-vs-Stage4
7.286400E-01
Stage1-vs-Stage2
6.950200E-01
Stage1-vs-Stage3
8.026000E-01
Stage1-vs-Stage4
9.221000E-01
Stage2-vs-Stage3
9.957000E-01
Stage2-vs-Stage4
8.681600E-01
Stage3-vs-Stage4
8.987600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.874400E-01
Normal-vs-AfricanAmerican
6.118000E-01
Normal-vs-Asian
7.122400E-01
Caucasian-vs-AfricanAmerican
8.715000E-01
Caucasian-vs-Asian
2.133000E-01
AfricanAmerican-vs-Asian
2.549000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.517800E-01
Normal-vs-Female
6.345200E-01
Male-vs-Female
5.951200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.766000E-01
Normal-vs-Age(41-60Yrs)
5.498200E-01
Normal-vs-Age(61-80Yrs)
7.851400E-01
Normal-vs-Age(81-100Yrs)
5.252800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.798630E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.658800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.163800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.808410E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.869200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.413400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.919400E-01
Normal-vs-Daily Drinker
5.604400E-01
Normal-vs-Weekly Drinker
8.430000E-01
Normal-vs-Occasional Drinker
9.844800E-01
Normal-vs-Social Drinker
8.829200E-01
Non Drinker-vs-Daily Drinker
1.599020E-01
Non Drinker-vs-Weekly Drinker
6.528800E-01
Non Drinker-vs-Occasional Drinker
9.822600E-01
Non Drinker-vs-Social Drinker
7.666200E-01
Daily Drinker-vs-Weekly Drinker
4.638200E-01
Daily Drinker-vs-Occasional Drinker
2.208600E-01
Daily Drinker-vs-Social Drinker
3.486200E-01
Weekly Drinker-vs-Occasional Drinker
7.188600E-01
Weekly Drinker-vs-Social Drinker
8.871200E-01
Occasional Drinker-vs-Social Drinker
8.152000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.505000E-01
Normal-vs-Grade 2
8.488000E-01
Normal-vs-Grade 3
8.398000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.560000E-02
Grade 1-vs-Grade 3
8.338300E-02
Grade 1-vs-Grade 4
9.505000E-01
Grade 2-vs-Grade 3
7.763600E-01
Grade 2-vs-Grade 4
8.488000E-01
Grade 3-vs-Grade 4
8.398000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.959600E-01
Normal-vs-NonDiabetic
8.630800E-01
Diabetic-vs-NonDiabetic
3.902400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.895000E-01
Normal-vs-NoPancreatitis
7.584800E-01
Pancreatitis-vs-NoPancreatitis
5.741800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.796200E-01
Normal-vs-N1
7.278800E-01
N0-vs-N1
6.192400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.232200E-01
Normal-vs-TP53-NonMutant
7.800800E-01
TP53-Mutant-vs-TP53-NonMutant
1.991000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
